Integral Health Asset Management as of Dec. 31, 2022
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 61 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 3.8 | $18M | 400k | 45.82 | |
| Cytokinetics Call Call Option | 3.8 | $18M | 400k | 45.82 | |
| Moderna (MRNA) | 3.8 | $18M | 100k | 179.62 | |
| BioMarin Pharmaceutical (BMRN) | 3.7 | $18M | 170k | 103.49 | |
| Merck & Co (MRK) | 3.5 | $17M | 150k | 110.95 | |
| Quest Diagnostics Incorporated (DGX) | 3.3 | $16M | 100k | 156.44 | |
| Inspire Med Sys (INSP) | 3.2 | $15M | 60k | 251.88 | |
| Zentalis Pharmaceuticals (ZNTL) | 3.2 | $15M | 750k | 20.14 | |
| Cigna Corp (CI) | 3.1 | $15M | 45k | 331.34 | |
| Madrigal Pharmaceuticals Put Put Option | 3.0 | $15M | 50k | 290.25 | |
| Universal Hlth Svcs CL B (UHS) | 3.0 | $14M | 100k | 140.89 | |
| Sage Therapeutics (SAGE) | 2.9 | $14M | 360k | 38.14 | |
| EXACT Sciences Corporation (EXAS) | 2.9 | $14M | 275k | 49.51 | |
| Guardant Health (GH) | 2.7 | $13M | 475k | 27.20 | |
| Anthem (ELV) | 2.7 | $13M | 25k | 512.97 | |
| Uniqure Nv SHS (QURE) | 2.6 | $13M | 550k | 22.67 | |
| Intuitive Surgical Com New (ISRG) | 2.5 | $12M | 44k | 265.35 | |
| Hca Holdings (HCA) | 2.2 | $10M | 43k | 239.96 | |
| Gilead Sciences (GILD) | 2.2 | $10M | 120k | 85.85 | |
| Sanofi Sponsored Adr (SNY) | 2.0 | $9.7M | 200k | 48.43 | |
| Astrazeneca Sponsored Adr (AZN) | 2.0 | $9.5M | 140k | 67.80 | |
| Relay Therapeutics (RLAY) | 2.0 | $9.3M | 625k | 14.94 | |
| Krystal Biotech (KRYS) | 1.9 | $9.1M | 115k | 79.22 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $8.3M | 35k | 237.65 | |
| Zimmer Holdings (ZBH) | 1.7 | $8.3M | 65k | 127.50 | |
| Centene Corporation (CNC) | 1.7 | $8.2M | 100k | 82.01 | |
| Abbvie (ABBV) | 1.7 | $8.1M | 50k | 161.61 | |
| Ventyx Biosciences (VTYX) | 1.4 | $6.9M | 210k | 32.79 | |
| Penumbra (PEN) | 1.4 | $6.7M | 30k | 222.46 | |
| Cardinal Health (CAH) | 1.4 | $6.5M | 84k | 76.87 | |
| Replimune Group (REPL) | 1.3 | $6.0M | 220k | 27.20 | |
| Aclaris Therapeutics (ACRS) | 1.2 | $5.8M | 370k | 15.75 | |
| Viking Therapeutics (VKTX) | 1.2 | $5.6M | 600k | 9.40 | |
| Iteos Therapeutics (ITOS) | 1.1 | $5.3M | 270k | 19.53 | |
| Intellia Therapeutics (NTLA) | 1.1 | $5.2M | 150k | 34.89 | |
| Teleflex Incorporated (TFX) | 1.0 | $5.0M | 20k | 249.63 | |
| Cooper Cos Com New | 1.0 | $5.0M | 15k | 330.67 | |
| Walgreen Boots Alliance (WBA) | 1.0 | $4.7M | 125k | 37.36 | |
| Chinook Therapeutics | 1.0 | $4.6M | 175k | 26.20 | |
| Revance Therapeutics (RVNC) | 0.9 | $4.4M | 240k | 18.46 | |
| Doximity Cl A (DOCS) | 0.9 | $4.4M | 131k | 33.56 | |
| Nevro (NVRO) | 0.9 | $4.3M | 109k | 39.60 | |
| Amicus Therapeutics (FOLD) | 0.8 | $4.0M | 327k | 12.21 | |
| Akero Therapeutics (AKRO) | 0.8 | $3.8M | 70k | 54.80 | |
| Ptc Therapeutics I (PTCT) | 0.8 | $3.8M | 100k | 38.17 | |
| Argenx Se Sponsored Adr (ARGX) | 0.8 | $3.8M | 10k | 378.83 | |
| Natera (NTRA) | 0.7 | $3.5M | 87k | 40.17 | |
| Envista Hldgs Corp (NVST) | 0.7 | $3.4M | 100k | 33.67 | |
| Reata Pharmaceuticals Cl A | 0.7 | $3.2M | 85k | 37.99 | |
| Privia Health Group (PRVA) | 0.6 | $3.0M | 130k | 22.71 | |
| Keros Therapeutics (KROS) | 0.6 | $2.9M | 60k | 48.02 | |
| Fibrogen (FGEN) | 0.6 | $2.8M | 175k | 16.02 | |
| Kymera Therapeutics (KYMR) | 0.5 | $2.5M | 100k | 24.96 | |
| DaVita (DVA) | 0.5 | $2.5M | 33k | 74.67 | |
| Prometheus Biosciences | 0.5 | $2.2M | 20k | 110.00 | |
| Rapt Therapeutics (RAPT) | 0.5 | $2.2M | 109k | 19.80 | |
| Irhythm Technologies (IRTC) | 0.4 | $1.9M | 20k | 93.67 | |
| Tg Therapeutics (TGTX) | 0.4 | $1.8M | 150k | 11.83 | |
| Supernus Pharmaceuticals (SUPN) | 0.3 | $1.4M | 40k | 35.67 | |
| Longboard Pharmaceuticals In (LBPH) | 0.2 | $792k | 243k | 3.26 | |
| Magenta Therapeutics | 0.0 | $164k | 416k | 0.40 |
